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Abstract
Background: MAMLD1 is known to be a causative gene for hypospadias. Although previous studies have indicated that
MAMLD1 mutations result in hypospadias primarily because of compromised testosterone production around the critical
period for fetal sex development, the underlying mechanism(s) remains to be clarified. Furthermore, although functional
studies have indicated a transactivation function of MAMLD1 for the non-canonical Notch target Hes3, its relevance to
testosterone production remains unknown. To examine these matters, we performed Mamld1 knockdown experiments.
Methodology/Principal Findings: Mamld1 knockdown was performed with two siRNAs, using mouse Leydig tumor cells
(MLTCs). Mamld1 knockdown did not influence the concentrations of pregnenolone and progesterone but significantly
reduced those of 17-OH pregnenolone, 17-OH progesterone, dehydroepiandrosterone, androstenedione, and testosterone
in the culture media. Furthermore, Mamld1 knockdown significantly decreased Cyp17a1 expression, but did not affect
expressions of other genes involved in testosterone biosynthesis as well as in insulin-like 3 production. Hes3 expression was
not significantly altered. In addition, while 47 genes were significantly up-regulated (fold change .2.06) and 38 genes were
significantly down-regulated (fold change ,0.56), none of them was known to be involved in testosterone production. Cell
proliferation analysis revealed no evidence for compromised proliferation of siRNA-transfected MLTCs.
Conclusions/Significance: The results, in conjunction with the previous data, imply that Mamld1 enhances Cyp17a1
expression primarily in Leydig cells and permit to produce a sufficient amount of testosterone for male sex development,
independently of the Hes3-related non-canonical Notch signaling.
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Introduction
MAMLD1 (mastermind-like domain containing 1, alias CXorf6)o n
human chromosome Xq28 is a causative gene for hypospadias, a
mild formof46,XYdisordersofsexdevelopment(DSD)[1].Todate,
multiple mutations have been identified in patients with various types
of hypospadias [1–3]. In this regard, the mouse homologous gene
Mamld1 is transiently expressed in fetal Sertoli and Leydig cells
around the critical period for sex development [1], and transient
Mamld1 knockdown using small interfering RNAs (siRNAs) reduces
testosterone (T) production in cultured mouse Leydig tumor cells
(MLTCs) [4]. Furthermore, the upstream region of MAMLD1/
Mamld1 harbors a putative binding site ‘‘CCAAGGTCA’’ for NR5A1
(alias, SF-1 and AD4BP) [4] that regulates the transcription of a vast
array of genes involved in sex development [5], and NR5A1 protein
has been shown to bind to the putative target site and exert a
transactivation function for Mamld1 [4]. These findings imply that
MAMLD1/Mamld1 is involved in fetal T production under the
regulation of NR5A1, and that MAMLD1 mutations result in
hypospadias primarilybecause of compromised T production around
the critical period for sex development.
However, the underlying mechanism(s) by which impaired
MAMLD1/Mamld1 leads to compromised T production remains to
be clarified, although there are several possibilities such as defective
activities of enzyme(s) involved in T production and compromised
proliferation of Leydig cells. Furthermore, although previous
functional studies have indicated that MAMLD1 has a transactivation
function for the non-canonical Notch target Hes3 [4], its relevance to
biological function including T production remains unknown. To
examine these matters, we performed detailed analyses in Mamld1
knockdown experiments using MLTCs.
Methods
Knockdown experiments
MLTCs (ATCC, CRL-2065
TM) were maintained in RPMI
1640 supplemented with 10% fetal bovine serum, and were
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GCUUCCAGUUCAGAUGCCATT; and anti-sense: UGG-
CAUCUGAACUGGAAGCTT) and siRNA2 (sense: GGAA-
CUAACCAAAAUUCAATT; and anti-sense: UUGAAUUUUG-
GUUAGUUCCTC) or with non-targeting control RNA (4611G)
(final concentration 20 nM), using Lipofectamine RNAiMAX
(Life Technologies). Relative amount of endogenous Mamld1
mRNA against B2m (b2-microglobulin) was determined by the
TaqMan real-time PCR method using the probe-primer mix on
ABI PRISM 7000 (Life Technologies) (Assay No.:
Mm01293665_m1 for Mamld1; and Mm00437762_m1 for B2m).
Steroid metabolite measurements
MLTCs are known to have the capacity to produce T primarily
via D
4-pathway, although the amount of T production remains
small primarily because of low 17a-hydroxylase and Hsd17b3
activities [6]. MLTCs are also known to retain responsiveness to
human chorionic gonadotropin (hCG) [6–8]. Thus, after 48 hours
of incubation of transfected MLTCs in 12-well plates with 1 ml of
culture medium (an initial cell count: 1610
5 cells/well), hCG
(Mochida Pharmaceutical) was added to the media at a final
concentration of 50 IU/L, and the culture media were obtained at
one hour after the addition of hCG. Subsequently, steroid
metabolites in the T production pathway were measured by the
liquid chromatography-tandem mass spectrometry (ASKA
Pharma Medical). This experiment was performed three times.
Gene expression analyses
Real-time reverse transcriptase (RT)-PCR and microarray
analyses were performed using total RNA extracted from MLTCs
that were harvested at the time of steroid metabolite measure-
ments. For real-time RT-PCR analysis, 1 mg of total RNA was
examined for relative mRNA dosage against B2m by the TaqMan
Gene Expression Assay on ABI PRISM 7000 (Assay No.:
Mm00446826_m l for Nr5a1 (Sf1); Mm00441558_m1 for Star;
Mm00490735_m1 for Cyp11a1; Mm01261921_mH for Hsd3b1;
and Mm00484040_m1 for Cyp17a1). In addition to the genes for
steroidogenic enzymes involved in T biosynthesis, we also studied
Insl3 (Mm01340353_m1) for gubernacular development that is
expressed in Leydig cells [9,10]. This experiment was repeated
three times. For microarray analysis, 300 ng of total RNA was
converted into cRNA associated with Cyanine-3 labeled CTP
using RNA Spike-In Kit and Quick Amp Labeling Kit, and was
subjected to hybridization on Whole Mouse Genome Oligo
Microarray in triplicate (4644 K G4122F) (Agilent Technolo-
gies). Subsequently, fluorescent signals were detected by Agilent
Scanner, and were analyzed by GeneSpring GX10 (Tomy Digital
Biology). The microarray data have been deposited in NCBI’s
Gene Expression Omnibus and are accessible through GEO
series accession number GSE26913 (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE26913). All data is MIAME
compliant and the raw data has been deposited in a MIAME
compliant database (GEO), as detailed on the MGED Society
website (http://www.mged.org/Workgroups/MIAME/miame.
html).
Cell proliferation assays
The number of viable MLTCs transfected with two siRNAs or
with non-targeting RNA was calculated by the colorimetric
method [11,12], using CellTiter 96 AQueous One Solution Cell
Proliferation Assay (Promega). The detailed procedure has been
described in the manufacturer’s protocol. In brief, MLTCs were
cultured in 96-well plates (an initial cell count: 1610
4 cells/well),
and the cell number was determined every 24 hours by measuring
the absorbance on a plate reader (Molecular Device) at 490 nm.
This method is based on a positive correlation between the
number of viable cells and the absorbance until the cells become
confluent, and our preliminary studies showed a good correlation
until the absorbance of ,2.0 (,6610
5 cells/well) (Figure S1). This
experiment was performed three times.
Statistical analysis
Statistical significance was examined by Student’s t-test or by
Mann-Whitney’s U-test. P,0.05 was considered significant.
Results
Steroid metabolite measurements
The mean steroid metabolite concentrations are shown in
Figure 1, together with the mean endogenous Mamld1 mRNA
levels that were markedly reduced in both siRNA1- and siRNA2-
transfected MLTCs at the time of steroid metabolite measure-
ments. The concentrations of pregnenolone and progesterone
remained comparable between the culture media with siRNA-
transfected MLTCs and those with non-targeted MLTCs, whereas
the concentrations of 17-OH pregnenolone, 17-OH progesterone,
dehydroepiandrosterone, androstenedione, and T were signifi-
cantly lower in the culture media with siRNA-transfected MLTCs
than in those with non-targeted MLTCs. Furthermore, compar-
ison of the steroid metabolite concentrations in the media with
non-targeted MLTCs confirmed revealed the D
4-pathway dom-
inant T production, markedly low 17a-hydroxylase activity and
well preserved 17/20 lyase activity for both D
4- and D
5-pathways,
and extremely low Hsd17b3 activity in MLTCs. These results
indicated that Mamld1 knockdown further reduced 17a-hydroxy-
lase activity that was originally low in MLTCs.
Gene expression analyses
Real-time RT-PCR and microarray analyses showed signifi-
cantly decreased Cyp17a1 expression (,70%) in both siRNA1- and
siRNA2-transfected MLTCs (Figure 2). Although Cyp11a1 and
Hsd3b1 expressions were found to be reduced in siRNA1-
transfected MLTCs by real-time RT-PCR and microarray
analyses respectively, such reduced activities were not reproduced
in siRNA2-transfected MLTCs. The siRNAs knockdown did not
affect the expressions of Nr5a1 (Sf1), Star, Por, and Insl3. The
assessment of Hsb17b3 was impossible, because of its extremely low
expression.
In addition, 47 genes including a Notch-related gene Hey1 were
significantly up-regulated (fold change .2.06) and 38 genes were
significantly down-regulated (fold change ,0.56) in both siRNA1-
and siRNA2-transfected MLTCs (Table S1 and Table S2).
However, Mamld1 knockdown had no discernible effect on the
Hes3 expression level (siRNA1: fold change 0.92, P=0.80; siRNA2:
fold change 1.43, P=0.35). The microarray data have been
deposited in NCBI’s Gene Expression Omnibus and are accessible
through GEO series accession number GSE26913 (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE26913).
Cell proliferation assays
The results are shown in Figure 3. The mean endogenous
Mamld1 mRNA levels were sufficiently suppressed for 120 hours in
both siRNA1- and siRNA2-transfected MLTCs. Under this
condition, the absorbance values for the siRNA-targeted and
non-targeted MLTCs showed a roughly linear increase until
72 hours (absorbance ,2.0). In this linear proliferative phase,
although the absorbance values were significantly decreased in
siRNA2-treated MLTCs at 24 and 48 hours after the transfection,
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72 hours of incubation, the MLTCs became confluent, and the
absorbance values became a plateau phase around ,2.0. In this
plateau phase, although the absorbance values at 96 hours after
the transfection were significantly low in both siRNA1- and
siRNA2-treated MLTCs, this was not reproduced at 120 hours
after the transfection.
Discussion
Mamld1 knockdown with two siRNAs resulted in compromised
T production, together with reduced 17a-hydroxylase activity and
Cyp17a1 expression in MLTCs. This provides further support for a
positive role of Mamld1 in T production [4], and implies for the
first time a possible interaction between Mamld1 and Cyp17a1,a t
least in MLTCs. In this regard, it is noteworthy that Mamld1 is
clearly expressed in fetal Leydig and Sertoli cells and is barely
expressed in adrenal cells [1,13], and that Cyp17a1 expression is
indispensable for T production in Leydig cells [14]. Thus, it
appears likely that Mamld1 enhances Cyp17a1 expression primarily
in Leydig cells, permitting the production of a sufficient amount of
T for male sex development. In addition, since the expressions of
other genes involved in T production and insulin-like 3
biosynthesis were not clearly affected in siRNA-transfected
MLTCs, this would argue against the possibility that Mamld1
knockdown causes a global dysfunction of MLTCs, resulting in T
hyposecretion.
Figure 1. Steroid metabolite concentrations. A. Steroid metabolic pathway from cholesterol to testosterone and enzymes involved in each
conversion. Pregnenolone, 17-OH pregnenolone, and DHEA (dehydroepiandrosterone) are D
4-steroid metabolites (D
4-pathway), and progesterone,
17-OH progesterone, and androstenedione are D
5-steroid metabolites (D
5-pathway). Hsd3b1 also functions as D
54isomerase. B. Steroid metabolite
concentrations in culture media and endogenous Mamld1 expression levels in MLTCs. The yellow, the green, and the blue bars indicate the data
obtained from MLTCs transfected with non-targeting RNA, siRNA1, and siRNA2, respectively. {: P,0.01; and {: P,0.001. The conversion factor to the
SI unit: cholesterol 0.026 (mmol/L), pregnenolone 3.16 (nmol/L), progesterone 3.18 (nmol/L), 17-OH pregnenolone 3.00 (pmol/L), 17-OH progesterone
3.03 (nmol/L), DHEA 3.46 (pmol/L), androstenedione 3.49 (nmol/L), and testosterone 3.46 (nmol/L).
doi:10.1371/journal.pone.0019123.g001
Figure 2. Gene expression analysis. The yellow, the green, and the
blue bars indicate the data obtained from MLTCs transfected with non-
targeting RNA, siRNA1, and siRNA2, respectively. *: P,0.05; {: P,0.01;
and {: P,0.001. A. Real-time RT-PCR analysis. B. Microarray analysis.
doi:10.1371/journal.pone.0019123.g002
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between impaired 17a-hydroxylase activity and reduced Cyp17a1
expression. Indeed, 17/20 lyase activity was well preserved in
siRNA-transfected MLTCs, although the same Cyp17a1 enzyme
is utilized for both17a-hydroxylase and 17/20 lyase reactions [14].
In addition, defective 17a-hydroxylase activity occurred in the
presence of ,70% of Cyp17a1 expression, despite 17a-hydroxylase
deficiency being an autosomal recessive disease in which 50% of
enzyme reduction has no major effect on the steroid metabolism
[14]. In this context, it is notable that MLTCs originally have a
markedly low 17a-hydroxylase activity and a well preserved 17/20
lyase activity for both D
4- and D
5-pathways (Figure 1) [6]. Such a
unique property of MLTCs may be relevant to the preferential
impairment of 17a-hydroxylase activity in siRNA-transfected
MLTCs.
Mamld1 knockdown had no discernible effect on the Hes3
expression. In addition, while a Notch-related gene Hey1 [15–17]
was up-regulated in siRNA-transfected MLTCs, there are no data
suggesting a possible interaction between Hes3 and Hey1 in the T
production process. Furthermore, while Hes3 is weakly expressed
in the MLTCs [4], Hes3 expression is apparently absent from
mouse fetal gonads around the critical period for sex development
[18]. Thus, it is unlikely that Hes3-related non-canonical Notch
signaling underlies a link between Mamld1 and Cyp17a1.I n
addition, while microarray analysis revealed multiple up-regulated
and down-regulated genes in siRNA-transfected MLTCs, none of
them is known to be involved in the T production at present. It
remains to be clarified, therefore, how Mamld1 enhances Cyp17a1
expression and T production.
The cell proliferation analysis revealed no clear evidence for the
reduced number of viable MLTCs transfected with siRNAs. This
implies that the reduced T and several other steroid metabolite
concentrations observed at 48 hours after the transfection
(Figure 1) are inexplicable by impaired proliferation of MLTCs.
However, since the cell doubling time of MLTCs is 35–40 hours
[8], a slight difference in cell proliferation would not be detected
by the present analysis. Thus, it might remain tenable at this time
that impaired cell proliferation becomes discernible after multiple
cell divisions, and that such a possibly reduced cell proliferation
underlies the development of hypospadias phenotype in patients
with MAMLD1 mutations, in addition to compromised T
production in Leydig cells.
In summary, the present study implies that Mamld1 enhances
Cyp17a1 expression primarily in Leydig cells and permit to
produce a sufficient amount of T for male sex development,
independently of the Hes3-related non-canonical Notch signaling.
Although the data were obtained from in vitro studies using
MLTCs, they provides a useful clue to clarify the underlying
factors for the development of hypospadias and other forms of
46,XY DSD.
Supporting Information
Figure S1 Cell proliferation assay by the colorimetric
method, using non-transfected MLTCs. The absorbance
value is well correlated with cell number until the absorbance
value of ,2.0, but does not reflect the cell number after the
absorbance value of ,2.0.
(TIF)
Table S1 List of up-regulated genes in MLTCs trasnfected with
siRNAs for Mamld1.
(DOC)
Table S2 List of down-regulated genes in MLTCs trasnfected
with siRNAs for Mamld1.
(DOC)
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